A patient with the classic features of Phelan‐McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72‐Mb deletion in the 22q13.2 region

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Medical Genetics. Part A

• Publication date

  2014-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ajmg.a.36358PMID 24375995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth in Phelan–McDermid syndrome

  2011cited by this paper
• Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome

  2011cited by this paper
• Association between deletion size and important phenotypes expands the genomic region of interest in Phelan–McDermid syndrome (22q13 deletion syndrome)

  2011cited by this paper
• Deletion Syndrome : Clinical and Molecular Analysis Using Array CGH

  2010cited by this paper
• Fulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome

  2010cited by this paper
• A de novo 7.9 Mb deletion in 22q13.2→qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings.

  2010cited by this paper
• Fulminant autoimmune hepatitis in a girl with 22q13 deletion syndrome: a previously unreported association

  2009cited by this paper
• Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language development

  2008influential reference
• Orphanet Journal of Rare Diseases BioMed Central Review Deletion 22q13.3 syndrome

  2008cited by this paper
• Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus

  2006cited by this paper
• Further delineation of the 22q13 deletion syndrome

  2005cited by this paper
• Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation

  2005cited by this paper
• NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling.

  2004cited by this paper
• 22q13 Deletion Syndrome: An Update and Review for the Primary Pediatrician

  2004cited by this paper
• Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum.

  2004cited by this paper
• Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations

  2003cited by this paper
• Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms

  2003cited by this paper
• BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF

  2001influential reference
• 22q13 deletion syndrome.

  2001cited by this paper
• Girl with accelerated growth, hearing loss, inner ear anomalies, delayed myelination of the brain, and del(22)(q13.1q13.2).

  2000cited by this paper
• Partial monosomy for chromosome 22 in a patient with del(22)(pter----q13.1::q13.33----qter).

  1990cited by this paper

• Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry

  2024cites this paper
• Dissecting the 22q13 region to explore the genetic and phenotypic diversity of patients with Phelan-McDermid syndrome.

  2023cites this paper
• Head Size in Phelan–McDermid Syndrome: A Literature Review and Pooled Analysis of 198 Patients Identifies Candidate Genes on 22q13

  2023cites this paper
• Brain Gene Co-Expression Network Analysis Identifies 22q13 Region Genes Associated with Autism, Intellectual Disability, Seizures, Language Impairment, and Hypotonia

  2023cites this paper
• Elevation of SHANK3 Levels by Antisense Oligonucleotides Directed Against the 3′-UTR of the Human SHANK3 mRNA

  2022cites this paper
• Phelan-McDermid syndrome: a classification system after 30 years of experience

  2022cites this paper
• Prenatal and postnatal diagnosis of Phelan–McDermid syndrome: A report of 21 cases from a medical center and review of the literature

  2022cites this paper
• Comparison of SHANK3 deficiency in animal models: phenotypes, treatment strategies, and translational implications

  2021cites this paper
• Genetic and metabolic profiling of individuals with Phelan‐McDermid syndrome presenting with seizures

  2021cites this paper
• Strong evidence for genotype–phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium

  2021cites this paper
• Genotype–phenotype correlation in Phelan‐McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes

  2021cites this paper
• A patient with Phelan‐McDermid syndrome and dilation of the great vessels

  2019cites this paper
• De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith–Magenis syndrome

  2019cites this paper
• Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome)

  2018cites this paper
• Framework for assessing individuals with rare genetic disorders associated with profound intellectual and multiple disabilities (PIMD): the example of Phelan McDermid Syndrome

  2018cites this paper
• Unilateral Opercular Po ymicrogyria in a Girl with 22 q 13 Deletion Syndrome

  2018cites this paper
• Identification of 22q13 genes most likely to contribute to Phelan McDermid syndrome

  2018cites this paper
• A previously unrecognized 22q13.2 microdeletion syndrome that encompasses TCF20 and TNFRSF13C

  2018influential citation
• Prospective longitudinal overnight video-EEG evaluation in Phelan-McDermid Syndrome.

  2018cites this paper
• Auto-immune disorders in a child with PIK3CD variant and 22q13 deletion.

  2018cites this paper
• Expression of SHANK3 in the Temporal Neocortex of Patients with Intractable Temporal Epilepsy and Epilepsy Rat Models

  2017cites this paper
• A CNV Catalogue

  2017cites this paper
• Genome-wide diagnostics of Mendelian disorders: from chromosomal microarrays to next-generation sequencing

  2017cites this paper
• Phelan–McDermid Syndrome: Clinical Aspects

  2016cites this paper
• Association of structural and numerical anomalies of chromosome 22 in a patient with syndromic intellectual disability.

  2016cites this paper
• Neurodevelopmental and immunological features in a child presenting 22q13.2 microdeletion

  2016influential citation
• Late-onset epileptic spasms in a patient with 22q13.3 deletion syndrome.

  2016cites this paper
• Letter to the editor regarding Disciglio et al.: Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome

  2015influential citation